HEATH CANADA HAS LICENSED NIRSEVIMAB (Beyfortus) for the prevention for RSV!!! It's a single dose antibody that can be used in term babies to protect them from RSV hospitalizations!

LET'S MAKE SURE THAT GOVERNMENTS ACROSS CANADA GIVE ACCESS TO NIRSEVIMAB FOR REMOTE AND RURAL INDIGENOUS BABIES!

WE ARE ALMOST THERE...

We are so proud of the quarter of a million people who have signed this petition to help make this happen!!